School of Medicine
Showing 1-10 of 22 Results
-
Abdullah Qatu, MD
Clinical Instructor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Qatu is a board-certified, fellowship-trained pain management specialist at the Stanford Health Care Pain Management Center. He is also a clinical instructor in the Department of Anesthesiology, Perioperative and Pain Medicine, Division of Pain Medicine, at Stanford University School of Medicine.
He specializes in the diagnosis and management of many different types of pain, including nerve pain, joint pain, cancer pain, low back and neck pain. Dr. Qatu obtained his medical degree from the New York University (NYU) Grossman School of Medicine. He continued on at NYU to complete his residency in anesthesiology after completing an internship in general surgery. He subsequently completed his pain medicine fellowship at Stanford University School of Medicine.
Dr. Qatu believes in utilizing a multimodal approach for pain management. This includes interventional, pharmacological, rehabilitative and psychological strategies. He is well-trained in a wide variety of interventional modalities that include injections, epidurals, nerve blocks, radiofrequency ablations, peripheral nerve stimulation, spinal cord/dorsal root ganglion stimulation and minimally invasive decompression. His research focuses on the clinical use of neuromodulation for various types of pain. In addition, he has investigated whether certain demographic and socioeconomic variables, as well as psychiatric illness, affect the outcomes of various orthopaedic traumas and surgeries. Dr. Qatu has presented his research at conferences throughout the U.S. and in Canada. -
Lei (Stanley) Qi
Associate Professor of Bioengineering
BioDr. Lei (Stanley) Qi is Associate Professor of Bioengineering, Sarafan ChEM-H, and a Chan Zuckerberg Biohub Investigator. Dr. Qi is a principal contributor to the development of CRISPR technologies for genome engineering beyond gene editing. His lab created the first nuclease-deactivated Cas9 (dCas9) for targeted gene regulation in cells. His lab has invented a CRISPR toolbox for engineering the epigenome, including CRISPRi and CRISPRa for targeted gene repression and activation, epigenome editing, LiveFISH for real-time DNA/RNA imaging, CRISPR-GO for 3D genome manipulation, CasMINI as a compact CRISPR system for gene therapy, hyperCas12a for multi-gene engineering, and CRISPR antivirals aimed at treating broad RNA viruses.
Dr. Qi obtained B.S. in Physics and Math from Tsinghua University in 2005, and Ph.D. in Bioengineering from the University of California, Berkeley in 2012. He was a Systems Biology Faculty Fellow at UCSF between 2012-2014, and joined Stanford faculty in 2014. His research focuses on mammalian synthetic biology, epigenetic engineering, immune cell engineering, directed evolution, and novel approaches for gene therapy. -
Xiang Qian
Stanford Medicine Endowed Director
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Professor (By courtesy), NeurosurgeryCurrent Research and Scholarly InterestsClinical Interests
-Pain Medicine:
Facial pain
Migraine and headache
Trigeminal Neuralgia and Glossopharyngeal neuralgia
Cancer Pain
Spine Disease
Neuropathic pain
Interventional Surgery
CT guided Procedure
Opioid Management
-Facial Nerve neuralgia and neuropathy
Hemifacial Spasm
CT guided awake RFA of facial nerve
Research Interests:
-Medical device development
-AI based headache diagnosis and management
-CT guided intervention
-Intra-nasal endoscopy guided procedure
-Optogenetics
-Mechanisms of neuropathic pain
-Ion channel and diseases
-Neurotoxicity of anesthetics -
Yushen Qian, MD
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
BioDr. Qian is a board-certified radiation oncologist and a clinical associate professor in the Stanford University School of Medicine, Department of Radiation Oncology.
In his clinical practice, he specializes in urologic, head and neck, and thoracic cancers, but treats a broad spectrum of cancers including lymphoma, gastrointestinal, and brain tumors. For each patient, he develops a comprehensive, compassionate care plan customized to individual needs. His goal is to deliver the most effective cancer treatment to help patients enjoy the best possible health and quality of life.
In addition to his clinical practice, Dr. Qian has conducted extensive research that is often focused on the impact of radiation therapy on patient outcomes and health care system costs.
He has presented the findings at annual meetings of the American Radium Society, American Society for Radiation Oncology, American Society of Clinical Oncology Cancer Survivorship Symposium, Palliative Care in Oncology Symposium, and elsewhere.
Dr. Qian has published articles in journals such as Clinical Cancer Research, the Journal of Clinical Oncology, Practical Radiation Oncology, the International Journal of Radiation Oncology • Biology • Physics (IJROBP), and more.
Dr. Qian co-authored the chapter on radiation therapy for liver tumors in the book Radiation Therapy for Hepatocellular Carcinoma: Clinical Data. He also co-authored the chapter on liver care for the book Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy.
He has earned numerous honors, including the Malcolm A. Bagshaw Award for leadership and outstanding scientific achievement. -
Xiaojie Qiu
Assistant Professor of Genetics
Current Research and Scholarly InterestsAt the Qiu Lab, our mission is to unravel and predict the intricacies of gene regulatory networks and cell-cell interactions pivotal in mammalian cell fate transitions over time and space, with a special emphasis on heart evolution, development, and disease. We are a dynamic and interdisciplinary team, harnessing the latest advancements in machine learning as well as single-cell and spatial genomics by integrating the predictive power of systems biology with the scalability of machine learning,
-
Lisa Nguy Quach
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsTransitions of care, end-of-life care, care for vulnerable populations and patients with primary languages other than English, quality improvement, medical education, mentorship